| Date | Name | Shares | Transaction | Value |
|
Dec 30, 2025
| Patrick J. Migliaccio Senior VP and COO, NJNG |
38,065
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $46.46 per share |
1,768,499.90
|
|
Apr 2, 2025
| Roberto F. Bel SVP and CFO |
22,649
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50 per share |
1,132,450.00
|
|
Jan 24, 2025
| M. Susan Hardwick Director |
14,502
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $47.79 per share |
693,050.58
|
|
Jan 24, 2025
| Peter C. Harvey Director |
2,825
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 24, 2025
| Gregory E. Aliff Director |
2,825
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 24, 2025
| Michael A. O'Sullivan Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jan 24, 2025
| Michael A. O'Sullivan Director |
N/A
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 24, 2025
| Michael A. O'Sullivan Director |
6,319
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $47.79 per share |
301,985.01
|
|
Jan 24, 2025
| M. Susan Hardwick Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jan 24, 2025
| M. Susan Hardwick Director |
2,825
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 24, 2025
| Sharon C. Taylor Director |
33,271
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $47.79 per share |
1,590,021.09
|
|
Jan 24, 2025
| Donald L. Correll Director |
3,976
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 24, 2025
| James H. DeGraffenreidt Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jan 24, 2025
| James H. DeGraffenreidt Director |
2,825
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 24, 2025
| James H. DeGraffenreidt Director |
20,104
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $47.79 per share |
960,770.16
|
|
Jan 24, 2025
| Jane M. Kenny Director |
2,825
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 24, 2025
| Thomas C. O'Connor Director |
2,825
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 24, 2025
| Sharon C. Taylor Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jan 24, 2025
| Sharon C. Taylor Director |
2,825
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|